Antiplatelet Therapy and Percutaneous Coronary Interventions

Simple item page
dc.contributor.authorHameau Davanzo, Rene
dc.contributor.authorFuensalida Alarcon, Alberto
dc.contributor.authorQuitral Calquin, Jorge
dc.contributor.authorSepulveda Varela, Pablo
dc.contributor.authorMartinez Sepulveda, Alejandro
dc.contributor.authorHerreros, Ramon Corbalan
dc.contributor.authorPatel, Sanjay
dc.contributor.authorMartinez Rodriguez, Gonzalo
dc.date.accessioned2024-01-10T14:23:42Z
dc.date.available2024-01-10T14:23:42Z
dc.date.issued2021
dc.description.abstractDual antiplatelet therapy is one of the cornerstones of modern percutaneous coronary interventions. The development of new therapeutic agents has significantly reduced ischemic events at the risk of increased bleeding complications. Therefore, efforts are currently focused on optimizing therapeutic algorithms to obtain the greatest anti-thrombotic benefit associated with the lowest risk of bleeding, that is, the greater net clinical benefit.
dc.description.abstractA significant number of trials evaluating different drug combinations or adjustments in treatment duration have been completed. However, clinical translation of these results is often difficult due to the heterogeneity of the therapeutic approaches.
dc.description.abstractThe aim of this manuscript is to provide an updated review of the literature regarding the use of dual antiplatelet therapy in patients undergoing coronary angioplasty and stenting.
dc.description.funderComision Nacional de Investigacion Cientifica y Tecnologica Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) Iniciacion
dc.description.funderANID Millennium Science Initiative Program
dc.fechaingreso.objetodigital2024-05-02
dc.format.extent12 páginas
dc.fuente.origenWOS
dc.identifier.doi10.2174/1573403X16666200615144423
dc.identifier.eissn1875-6557
dc.identifier.issn1573-403X
dc.identifier.pubmedidMEDLINE:32538731
dc.identifier.urihttps://doi.org/10.2174/1573403X16666200615144423
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/80131
dc.identifier.wosidWOS:000654214900001
dc.information.autorucFacultad de Medicina; Fuenzalida Alarcon, Alberto Javier; S/I; 209476
dc.information.autorucFacultad de Medicina; Sepulveda Varela, Pablo Andres; S/I; 1095919
dc.issue.numero3
dc.language.isoen
dc.nota.accesocontenido parcial
dc.pagina.final243
dc.pagina.inicio232
dc.publisherBENTHAM SCIENCE PUBL LTD
dc.revistaCurrent Cardiology Reviews
dc.rightsacceso restringido
dc.subjectAntiplatelet therapy
dc.subjectpercutaneous coronary interventions
dc.subjectthrombosis
dc.subjectangioplasty
dc.subjectclopidogrel
dc.subjectprasugrel
dc.subjectticagrelor
dc.subjectACUTE MYOCARDIAL-INFARCTION
dc.subjectST-SEGMENT ELEVATION
dc.subjectDRUG-ELUTING STENTS
dc.subjectHIGH-RISK PATIENTS
dc.subjectANTICOAGULANT-THERAPY
dc.subjectFOCUSED UPDATE
dc.subjectPLATELET INHIBITION
dc.subjectELDERLY-PATIENTS
dc.subjectLEFT MAIN
dc.subject2017 ESC
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleAntiplatelet Therapy and Percutaneous Coronary Interventions
dc.typeartículo de revisión
dc.volumen17
sipa.codpersvinculados209476
sipa.codpersvinculados1095919
sipa.indexWOS
sipa.trazabilidadCarga SIPA;09-01-2024
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Antiplatelet Therapy And Percutaneous Coronary Interventions.pdf
Size:
94.34 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas